Affinity Asset Advisors’s Acceleron Pharma Inc. XLRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-35,350
| Closed | -$6.08M | – | 82 |
|
|
2021
Q3 | $6.08M | Sell |
35,350
-19,650
| -36% | -$3.38M | 1.54% | 12 |
|
|
2021
Q2 | $6.9M | Buy |
55,000
+10,000
| +22% | +$1.25M | 2.47% | 9 |
|
|
2021
Q1 | $6.1M | Hold |
45,000
| – | – | 2.07% | 8 |
|
|
2020
Q4 | $5.76M | Buy |
+45,000
| New | +$5.76M | 3.05% | 7 |
|